Literature DB >> 20970439

Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice.

Toshiyuki Kawasaki1, Yukio Ago, Koji Yano, Ryota Araki, Yusuke Washida, Hirotaka Onoe, Shigeyuki Chaki, Atsuro Nakazato, Hitoshi Hashimoto, Akemichi Baba, Kazuhiro Takuma, Toshio Matsuda.   

Abstract

Post-weaning social isolation in rodents induces behavioral alterations, including hyperlocomotion, depression- and anxiety-like behaviors, aggression, and learning and memory deficits. These behavioral abnormalities may be related to the core symptoms in patients with neuropsychiatric disorders, such as schizophrenia and depression. In view of the recent studies that the group II metabotropic glutamate receptor (mGluR2/3) is involved in neuropsychiatric disorders, the present study examined the effect of isolation rearing on the binding of the mGluR2/3 antagonist [(3)H]LY341495 to mGluR2/3 in the mouse brain by in vitro autoradiography. The [(3)H]LY341495 binding in the prefrontal cortex, cerebral cortical layers I-III and hippocampus was significantly increased by rearing in social isolation while the binding in other brain regions was not altered. A saturation binding study of hippocampal membranes from isolation-reared mice revealed that the B(max) value increased significantly without any changes in the K(d) value. Moreover, the mGluR2/3 antagonist MGS0039 (1.0mg/kg, intraperitoneally) decreased the immobility time of isolation-reared mice in the forced swim test. These results suggest that isolation rearing causes an increase in mGluR2/3 densities in the prefrontal cortex and hippocampus and that the increased receptor function may contribute to pathogenic mechanisms for depression-like behavior of the isolation-reared mice.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20970439     DOI: 10.1016/j.neuropharm.2010.10.009

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  8 in total

1.  Anti-anhedonic effect of selective serotonin reuptake inhibitors with affinity for sigma-1 receptors in picrotoxin-treated mice.

Authors:  S Hasebe; Y Ago; Y Watabe; S Oka; N Hiramatsu; T Tanaka; C Umehara; H Hashimoto; K Takuma; T Matsuda
Journal:  Br J Pharmacol       Date:  2017-01-26       Impact factor: 8.739

2.  Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors.

Authors:  E Venzala; A L García-García; N Elizalde; P Delagrange; R M Tordera
Journal:  Psychopharmacology (Berl)       Date:  2012-06-16       Impact factor: 4.530

Review 3.  Potential of Glutamate-Based Drug Discovery for Next Generation Antidepressants.

Authors:  Shigeyuki Chaki; Kenichi Fukumoto
Journal:  Pharmaceuticals (Basel)       Date:  2015-09-17

4.  The Female Encounter Test: A Novel Method for Evaluating Reward-Seeking Behavior or Motivation in Mice.

Authors:  Yukio Ago; Shigeru Hasebe; Saki Nishiyama; Satoshi Oka; Yusuke Onaka; Hitoshi Hashimoto; Kazuhiro Takuma; Toshio Matsuda
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-29       Impact factor: 5.176

Review 5.  Allosteric Modulators of Metabotropic Glutamate Receptors as Novel Therapeutics for Neuropsychiatric Disease.

Authors:  Deborah J Luessen; P Jeffrey Conn
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

Review 6.  The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders.

Authors:  Daniel Peterlik; Peter J Flor; Nicole Uschold-Schmidt
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

7.  5-HT2CR antagonist/5-HT2CR inverse agonist recovered the increased isolation-induced aggressive behavior of BALB/c mice mediated by ADAR1 (p110) expression and Htr2c RNA editing.

Authors:  Weizhi Yu; Hong Xu; Ying Xue; Dong An; Huairui Li; Wei Chen; Deqin Yu; Yiping Sun; Jianmei Ma; Yiyuan Tang; Zhaoyang Xiao; Shengming Yin
Journal:  Brain Behav       Date:  2018-02-07       Impact factor: 2.708

Review 8.  Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders.

Authors:  Shalini Dogra; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2021-06-25       Impact factor: 5.273

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.